dyphylline has been researched along with Chemical and Drug Induced Liver Injury in 9 studies
Dyphylline: A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.
dyphylline : An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.
Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Warner, DJ | 1 |
| Chen, H | 1 |
| Cantin, LD | 1 |
| Kenna, JG | 1 |
| Stahl, S | 1 |
| Walker, CL | 1 |
| Noeske, T | 1 |
| Chen, M | 1 |
| Suzuki, A | 1 |
| Thakkar, S | 1 |
| Yu, K | 1 |
| Hu, C | 1 |
| Tong, W | 1 |
| Chalasani, N | 3 |
| Bonkovsky, HL | 3 |
| Stine, JG | 1 |
| Gu, J | 5 |
| Barnhart, H | 6 |
| Jacobsen, E | 1 |
| Björnsson, E | 1 |
| Fontana, RJ | 5 |
| Kleiner, DE | 5 |
| Hoofnagle, JH | 5 |
| Hayashi, PH | 3 |
| Lucena, MI | 1 |
| Bjornsson, ES | 1 |
| Aithal, GP | 1 |
| Gonzalez-Jimenez, A | 1 |
| Yang, Q | 1 |
| Andrade, RJ | 1 |
| Ahmad, J | 2 |
| Barnhart, HX | 1 |
| Bonacini, M | 1 |
| Ghabril, M | 2 |
| Odin, JA | 1 |
| Rockey, DC | 1 |
| Rossi, S | 1 |
| Serrano, J | 1 |
| Tillmann, HL | 1 |
| Devarbhavi, H | 1 |
| Patil, M | 1 |
| Raj, S | 1 |
| Engle, RE | 1 |
| Nguyen, H | 1 |
| Farci, P | 1 |
| Li, YJ | 1 |
| Dellinger, A | 1 |
| Navarro, V | 2 |
| Bonkovsky, H | 1 |
| Phillips, E | 2 |
| Lammert, C | 1 |
| Schwantes-An, TH | 1 |
| Nicoletti, P | 1 |
| Halegoua-DeMarzio, D | 1 |
| Avula, B | 1 |
| Barritt, AS | 1 |
| Ghabril, MS | 1 |
| Khan, IA | 1 |
| Stolz, A | 1 |
| Vuppalanchi, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury[NCT00345930] | 4,000 participants (Anticipated) | Observational | 2004-09-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dyphylline and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
8 other studies available for dyphylline and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.
Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Chemical and Drug Ind | 2022 |
A revised electronic version of RUCAM for the diagnosis of DILI.
Topics: Causality; Chemical and Drug Induced Liver Injury; Dyphylline; Electronics; Humans; Reproducibility | 2022 |
Value of liver biopsy in the diagnosis of drug-induced liver injury.
Topics: Biopsy; Chemical and Drug Induced Liver Injury; Dyphylline; Humans; Risk Factors | 2022 |
Leflunomide-induced liver injury: Differences in characteristics and outcomes in Indian and US registries.
Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Drug-Relate | 2022 |
Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study.
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Dyphylline; Hepatitis Antibodies; Hepat | 2022 |
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Dyphylline; | 2023 |
Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Curcuma; Dyphylline; Female; Hepatitis; Humans; | 2023 |